Vendor, Louisville, CO
Bolder Biotechnology Inc.
UEI CJ6GFX2TU3J4, CAGE 1PUB8
1 award and $1,428,550 obligated between April 18, 2024 and March 27, 2026, 100% under full and open competition, against 16.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,428,550 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00011Definitive Contract, April 18, 2024, Full and Open Competition, 16 offers | National Institutes of Health NiaidNational Institutes of Health | Advanced Development of BBT-059 as a Radiation Medical Countermeasure for Dosing Up to 48H Post Exposure"NAICS 541714, PSC AN12 | $1,428,550 |
- Places of performance
- Colorado
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 4 across 1 awards